Innovating Works

H2020

Cerrada
HORIZON-HLTH-2022-STAYHLTH-02-01
Personalised blueprint of chronic inflammation in health-to-disease transition
ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 1 “Staying healthy in a rapidly changing society”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to several of the following expected outcomes:
Sólo fondo perdido 100%
Europeo
Mostrando 81 al 100 de 230 resultados
RETEX: Regenerated Cotton for Electronic Textiles ISTANBUL TEKNIK UNIVERSITESI tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 The main objective of the RETEX MSCA SE project is to form a world class international and inter-sectoral network of organizations, working...
2023-01-01 - 2026-12-31 | Financiado
Invest4Health: Mobilising novel finance models for health promotion and disease prevention REGION SKANE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 In the medium to longer-term, the fiscal space that governments have to provide additional budgetary resources will shrink, including for he...
2023-01-01 - 2026-06-30 | Financiado
REALM: Real-world-data Enabled Assessment for heaLth regulatory decision-Making UNIVERSITEIT MAASTRICHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 The overall aim of the REALM project is to create a collaborative framework for regulatory authorities, application developers, healthcare p...
2023-01-01 - 2026-12-31 | Financiado
CARE-IN-HEALTH: CArdiovascularREsolution of INflammation to promote HEALTH INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular diseases (CVD) represent a sign...
2023-01-01 - 2027-12-31 | Financiado
IMMEDIATE: Imminent Disease Prediction and Prevention at the Environment Host Interface CHARITE UNIVERSITAETSMEDIZIN BERLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 IMMEDIATE aims to investigate and explore the diet-microbiome-immunometabolism-axis as a sensor for health-to-disease transition and evaluat...
2023-01-01 - 2026-12-31 | Financiado
INITIALISE: Inflammation in human early life: targeting impacts on life-course health TURUN YLIOPISTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The development of the human immune system in early life, including in utero, impacts the risks of several diseases later in life, particula...
2023-01-01 - 2028-12-31 | Financiado
miGut-Health: Personalised blueprint intestinal health UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The miGut-Health consortium aims to develop a personalized blueprint of intestinal health to predict and prevent inflammatory bowel disease....
2023-01-01 - 2026-12-31 | Financiado
Hypermarker: Personalised pharmacometabolomic optimisation of treatment for hypertension UNIVERSITAIR MEDISCH CENTRUM UTRECHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Hypertension, or high blood pressure (BP), is a serious medical condition, and the single biggest contributor to circulatory diseases which...
2023-01-01 - 2026-12-31 | Financiado
Real4Reg: Development, optimisation and implementation of artificial intelligence methods for real world data... BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Real-world evidence derived from real-world data (RWD) has a promising role to inform regulatory decision-making. Based on highly relevant u...
2023-01-01 - 2026-12-31 | Financiado
CAPHE: Communities and Artistic Participation in Hybrid Environment UNIWERSYTET JAGIELLONSKI tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01-01 The aim of the project is to investigate and perform the possibility of elaboration of an enhanced model of interaction and somatic particip...
2023-01-01 - 2026-12-31 | Financiado
iPROLEPSIS: iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A... ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up...
2023-01-01 - 2026-12-31 | Financiado
ENDOTARGET: Systemic Endotoxemia as the driver of chronic inflammation - Biomarkers and novel therapeutic target... HUSYHTYMA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 Rheumatic diseases (RDs) affect more than 40% of Europe's population and cause significant disability, pain, reduced lifespan and a very hig...
2023-01-01 - 2026-12-31 | Financiado
MARCHES: Methodologies for Assessing the Real Costs to Health of Environmental Stressors AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 To underpin regular use of integrated economic and health modeling in impact assessments and socio-economic analysis by public authorities,...
2023-01-01 - 2026-12-31 | Financiado
PRUDENT: Prioritization, incentives and Resource use for sUstainable DENTistry STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 Oral diseases and conditions are the 3rd most expensive diseases to treat in the EU. They affect about half of the EU population. As highlig...
2023-01-01 - 2027-12-31 | Financiado
BEST-COST: Burden of disease based methods for estimating the socio-economic cost of environmental stressors SCIENSANO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-ENVHLTH-04-01 The outdoor environment has a significant impact on our health and wellbeing. The European Green Deal has introduced the ambitious commitmen...
2023-01-01 - 2026-12-31 | Financiado
INTERCEPT-T2D: Early Interception of Inflammatory-mediated Type 2 Diabetes INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The overall concept of INTERCEPT-T2D is to establish whether an inflammatory-mediated profile contributes to the onset of Type 2 Diabetes (T...
2023-01-01 - 2027-12-31 | Financiado
PRIME-CKD: Personalized Drug Response: IMplementation and Evaluation in CKD ACADEMISCH ZIEKENHUIS GRONINGEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Chronic Kidney Disease (CKD) is one of the major causes of death in high income countries and its prevalence is growing rapidly. New therapi...
2023-01-01 - 2027-12-31 | Financiado
FLASH: Flexible Approaches to Support Health through financing UNIVERSITA DEGLI STUDI DI VERONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08-02 One of the lessons learnt from the Covid-19 pandemic is the importance of flexibility in funding and organization of health systems. Europea...
2023-01-01 - 2026-12-31 | Financiado
REDDIE: Real-world evidence for decisions in diabetes MEDIZINISCHE UNIVERSITAT GRAZ tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11-01 Randomised controlled trials are the cornerstone of evidence-based medicine. However, the digitisation of real-world data (RWD) including da...
2023-01-01 - 2026-12-31 | Financiado
PRAESIIDIUM: PHYSICS INFORMED MACHINE LEARNING-BASED PREDICTION AND REVERSION OF IMPAIRED FASTING GLUCOSE MANAGEM... SPINDOX LABS SRL tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02-01 The incidence of undiagnosed diabetes accounts for 36% European adults, while 541M adults worldwide have Impaired Glucose Tolerance (IGT), a...
2023-01-01 - 2025-12-31 | Financiado